| scholarly article | Q13442814 |
| P50 | author | Heikki Ruskoaho | Q18633591 |
| Jarno Salonen | Q56550083 | ||
| Sini Kinnunen | Q59684387 | ||
| Mika Välimäki | Q59684391 | ||
| Jouni Hirvonen | Q61163249 | ||
| Pauli Ohukainen | Q92150047 | ||
| Marja A Tölli | Q114442475 | ||
| Jaana Rysä | Q43523475 | ||
| Raisa Serpi | Q47504213 | ||
| Ermei Mäkilä | Q41554703 | ||
| Hélder A. Santos | Q43143343 | ||
| P2093 | author name string | Erhe Gao | |
| Zoltan Szabo | |||
| Alexandra Correia | |||
| Mónica P A Ferreira | |||
| P2860 | cites work | Csx/Nkx2-5 is required for homeostasis and survival of cardiac myocytes in the adult heart | Q24292433 |
| The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors | Q24314957 | ||
| Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart | Q24606117 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells | Q27860599 | ||
| Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases | Q28068965 | ||
| Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA | Q28362213 | ||
| The Cardiac Tissue-Restricted Homeobox Protein Csx/Nkx2.5 Physically Associates with the Zinc Finger Protein GATA4 and Cooperatively Activates Atrial Natriuretic Factor Gene Expression | Q28504813 | ||
| Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart | Q28509556 | ||
| The transcription factor GATA-6 regulates pathological cardiac hypertrophy | Q28512555 | ||
| Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension | Q28569488 | ||
| GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program | Q28569972 | ||
| Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure | Q28576829 | ||
| Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors | Q28589872 | ||
| Gene regulatory networks in the evolution and development of the heart | Q29619086 | ||
| In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes | Q29620599 | ||
| Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity | Q30500787 | ||
| Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability | Q57396510 | ||
| Combinatorial interactions regulating cardiac transcription | Q57968965 | ||
| p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms | Q60667645 | ||
| Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways | Q43865809 | ||
| Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming | Q46195954 | ||
| GATA-4 is an angiogenic survival factor of the infarcted heart | Q46454363 | ||
| Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart | Q47857175 | ||
| Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5. | Q47877045 | ||
| Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy. | Q50259289 | ||
| Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. | Q52178778 | ||
| Pressure overload increases GATA4 binding activity via endothelin-1. | Q31825806 | ||
| Cardiogenic small molecules that enhance myocardial repair by stem cells | Q33329047 | ||
| Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. | Q33782859 | ||
| Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases | Q33852885 | ||
| (Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function. | Q34387893 | ||
| A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse | Q34423842 | ||
| Small molecules for cell reprogramming and heart repair: progress and perspective | Q35076609 | ||
| Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure | Q35131260 | ||
| Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo | Q35134084 | ||
| Natriuretic peptides and myocardial ischaemia | Q35667258 | ||
| GATA transcription factors in the developing and adult heart | Q35833907 | ||
| Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5. | Q35862534 | ||
| Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases | Q36144681 | ||
| In search of new therapeutic targets and strategies for heart failure: recent advances in basic science | Q36364300 | ||
| Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells | Q36513042 | ||
| Epidemiology and aetiology of heart failure | Q36905978 | ||
| Medical therapy for chronic heart failure | Q37920401 | ||
| Transcription Factors in Heart: Promising Therapeutic Targets in Cardiac Hypertrophy | Q38023555 | ||
| Early left ventricular gene expression profile in response to increase in blood pressure. | Q38302190 | ||
| Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors | Q38360604 | ||
| Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics | Q38654054 | ||
| Adverse Remodeling and Reverse Remodeling After Myocardial Infarction | Q38665321 | ||
| Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling | Q38676235 | ||
| In vitro and in vivo assessment of heart-homing porous silicon nanoparticles | Q38877084 | ||
| Evolving approaches to heart regeneration by therapeutic stimulation of resident cardiomyocyte cell cycle. | Q39016129 | ||
| In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart. | Q39166414 | ||
| Regulated Expression of pH Sensing G Protein-Coupled Receptor-68 Identified through Chemical Biology Defines a New Drug Target for Ischemic Heart Disease | Q39371869 | ||
| Ca2+–calmodulin‐dependent protein kinase II represses cardiac transcription of the L‐type calcium channel α1C‐subunit gene (Cacna1c) by DREAM translocation | Q39559824 | ||
| SUMO-1 modification activated GATA4-dependent cardiogenic gene activity | Q40520891 | ||
| Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. | Q40675868 | ||
| Dual effects of the homeobox transcription factor Csx/Nkx2-5 on cardiomyocytes | Q40693364 | ||
| Heart repair by reprogramming non-myocytes with cardiac transcription factors | Q41859789 | ||
| VUT-MK142 : a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes. | Q42031179 | ||
| Targeting Native Adult Heart Progenitors with Cardiogenic Small Molecules | Q42203093 | ||
| Combinatorial interactions regulating cardiac transcription | Q42456434 | ||
| Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies | Q42635760 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4611 | |
| P577 | publication date | 2018-03-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction | |
| P478 | volume | 8 |
| Q62923934 | Cardiomyocyte-Endothelial Cell Interactions in Cardiac Remodeling and Regeneration |
| Q90415843 | GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes |
| Q59792458 | Role of Overexpressed Transcription Factor FOXO1 in Fatal Cardiovascular Septal Defects in Patau Syndrome: Molecular and Therapeutic Strategies |
| Q89482564 | Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds |
| Q92731445 | Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators |
| Q92659552 | Targeting GATA4 for cardiac repair |
Search more.